Silvant Capital Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,732
| Closed | -$124K | – | 337 |
|
|
2022
Q1 | $124K | Hold |
3,732
| – | – | 0.02% | 210 |
|
|
2021
Q4 | $122K | Sell |
3,732
-239
| -6% | -$7.81K | 0.02% | 208 |
|
|
2021
Q3 | $166K | Hold |
3,971
| – | – | 0.03% | 195 |
|
|
2021
Q2 | $154K | Hold |
3,971
| – | – | 0.02% | 205 |
|
|
2021
Q1 | $135K | Hold |
3,971
| – | – | 0.02% | 211 |
|
|
2020
Q4 | $180K | Hold |
3,971
| – | – | 0.03% | 191 |
|
|
2020
Q3 | $109K | Hold |
3,971
| – | – | 0.02% | 212 |
|
|
2020
Q2 | $146K | Hold |
3,971
| – | – | 0.03% | 195 |
|
|
2020
Q1 | $129K | Hold |
3,971
| – | – | 0.03% | 183 |
|
|
2019
Q4 | $163K | Hold |
3,971
| – | – | 0.03% | 195 |
|
|
2019
Q3 | $141K | Buy |
3,971
+1,400
| +54% | +$49.7K | 0.03% | 193 |
|
|
2019
Q2 | $132K | Hold |
2,571
| – | – | 0.02% | 214 |
|
|
2019
Q1 | $147K | Buy |
+2,571
| New | +$147K | 0.03% | 206 |
|